
Keensight hires new associate director

French mid-market house Keensight Capital has hired Theodor Wuppermann as associate director.
Wuppermann previously spent two and a half years at healthcare-focused investor ArchiMed. He notably worked on the deal for Micromed, a Franco-Italian manufacturer of high-end neurology devices. Prior to that, he started his career at Capiton, where he stayed for four years.
According to his LinkedIn profile, Wuppermann joined Keensight in June.
R Capital Management span out from the Rothschild group and rebranded as Keensight Capital in 2013. It is not the first time the firm has hired talent from its peer ArchiMed: David Piccoli, a co-founder and senior analyst at the healthcare specialist, left to join Keensight in early 2016.
Keensight recently launched its Keensight Capital V vehicle targeting a €750m final close, significantly more than its predecessor. The fifth generation fund will pursue a very similar strategy to its predecessor, Keensight Capital IV, investing in companies with revenues in the range of €15-250m and related to the information technology, internet, healthcare and wellbeing sectors.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater